Celldex Therapeutics (CLDX) Earnings Date, Estimates & Call Transcripts → [Shocking] Elon Musk’s Plan To End Banks (From Crypto 101 Media) (Ad) Free CLDX Stock Alerts $38.85 +0.87 (+2.29%) (As of 04/22/2024 ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Earnings SummaryUpcoming Earnings DateMay. 2EstimatedActual EPS (Feb. 26) -$0.57 Beat By $0.19 Consensus EPS (Feb. 26) -$0.76 Get Celldex Therapeutics Earnings AlertsEnter your email address below to receive the latest news and earnings results for CLDX and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueCLDX Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.CLDX Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Crypto 101 Media[Shocking] Elon Musk’s Plan To End BanksLeaked Elon Musk call reveals shocking plan to replace banks. As Musk's plan rolls out, industry experts predict it could spark a wave of mass crypto adoption. Triggering a new crypto bull run. While helping drive a booming crypto asset class up from $2.5-billion to $16-trillion (a 6,400x increase) by 2030. Click here now to get your copy. Celldex Therapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20242($0.67)($0.64)($0.66)Q2 20242($0.69)($0.67)($0.68)Q3 20242($0.74)($0.73)($0.74)Q4 20242($0.79)($0.78)($0.79)FY 20248($2.89)($2.82)($2.86)CLDX Earnings Date and InformationCelldex Therapeutics last released its quarterly earnings results on February 26th, 2024. The biopharmaceutical company reported ($0.57) earnings per share for the quarter, topping the consensus estimate of ($0.76) by $0.19. The company had revenue of $4.13 million for the quarter, compared to the consensus estimate of $1.20 million. Celldex Therapeutics has generated ($2.91) earnings per share over the last year (($2.91) diluted earnings per share). Earnings for Celldex Therapeutics are expected to decrease in the coming year, from ($2.85) to ($3.36) per share. Celldex Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, May 2nd, 2024 based off prior year's report dates.Read More Celldex Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 5/2/2024Estimated)------- 2/26/2024Q4 2023($0.76)($0.57)+$0.19($0.31)$1.20 million$4.13 million11/2/2023Q3 2023($0.67)($0.81)($0.14)($0.81)$0.60 million$1.52 million8/8/2023Q2 2023($0.65)($0.65)-($0.65)$0.67 million$0.27 million5/4/2023Q1 2023($0.63)($0.62)+$0.01($0.62)$0.38 million$0.97 million2/28/2023Q4 2022($0.59)($0.56)+$0.03($0.56)$0.16 million$1.61 million11/9/2022Q3 2022($0.57)($0.57)-($0.57)$0.25 million$0.41 million Get the Latest News and Ratings for CLDX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Celldex Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 8/8/2022Q2 2022($0.43)($0.58)($0.15)($0.39)$0.35 million$0.16 million5/5/2022Q1 2022($0.46)($0.49)($0.03)($0.49)$0.75 million$0.17 million2/28/2022Q4 2021($0.42)($0.43)($0.01)($0.43)$1.39 million$0.33 million 11/9/2021Q3 2021($0.36)($0.45)($0.09)($0.33)$1.70 million$0.15 million8/5/2021Q2 2021($0.40)($0.34)+$0.06($0.34)$1.13 million$3.48 million5/6/2021Q1 2021($0.35)($0.42)($0.07)($0.42)$1.13 million$0.69 million Celldex Therapeutics Earnings - Frequently Asked Questions When is Celldex Therapeutics's earnings date? Celldex Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, May 2nd, 2024 based off last year's report dates. Learn more on CLDX's earnings history. Did Celldex Therapeutics beat their earnings estimates last quarter? In the previous quarter, Celldex Therapeutics (NASDAQ:CLDX) reported ($0.57) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.76) by $0.19. Learn more on analysts' earnings estimate vs. CLDX's actual earnings. How much revenue does Celldex Therapeutics generate each year? Celldex Therapeutics (NASDAQ:CLDX) has a recorded annual revenue of $6.88 million. How much profit does Celldex Therapeutics generate each year? Celldex Therapeutics (NASDAQ:CLDX) has a recorded net income of -$141.43 million. CLDX has generated -$2.91 earnings per share over the last four quarters. What is Celldex Therapeutics's EPS forecast for next year? Celldex Therapeutics's earnings are expected to decrease from ($2.85) per share to ($3.36) per share in the next year. More Earnings Resources from MarketBeat Related Companies: RIOT Earnings MYGN Earnings NTLA Earnings NEOG Earnings QDEL Earnings LNTH Earnings TGTX Earnings AMN Earnings LFST Earnings TNDM Earnings Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Taiwan Semiconductor Earnings: AI Dominance and Future OutlookCSX Co.: The Railroad Powering Ahead with an Earnings Beat What's Driving Tesla Lower Ahead of its Earnings?Blackrock vs. State Street: Earnings in a Volatile MarketWhat to Expect From the Q1 Earnings Reporting SeasonLululemon Stock Implodes Post Earnings, Guidance Muted Applied Optoelectronics earnings dumper, pain now for gain later? This page (NASDAQ:CLDX) was last updated on 4/23/2024 by MarketBeat.com Staff From Our PartnersThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingHealthcare Takes A Big Step Forward With The Help Of AIThe Bull Reporttop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyDid You Get Your Free Bitcoin Yet?Crypto Swap Profits[Shocking] Elon Musk’s Plan To End BanksCrypto 101 MediaForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressMan Who Predicted 2008: “This Will be Worse.”AltimetryThe #1 Crypto for 2024InvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Celldex Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
